Nurix Therapeutics Inc
NASDAQ:NRIX

Watchlist Manager
Nurix Therapeutics Inc Logo
Nurix Therapeutics Inc
NASDAQ:NRIX
Watchlist
Price: 24.58 USD 2.12% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Nurix Therapeutics Inc?
Write Note

Nurix Therapeutics Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nurix Therapeutics Inc
Income from Continuing Operations Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Nurix Therapeutics Inc
NASDAQ:NRIX
Income from Continuing Operations
-$143.9m
CAGR 3-Years
-49%
CAGR 5-Years
-72%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Income from Continuing Operations
$5.4B
CAGR 3-Years
-7%
CAGR 5-Years
5%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Income from Continuing Operations
$1B
CAGR 3-Years
-41%
CAGR 5-Years
-30%
CAGR 10-Years
-18%
Amgen Inc
NASDAQ:AMGN
Income from Continuing Operations
$3.1B
CAGR 3-Years
-18%
CAGR 5-Years
-17%
CAGR 10-Years
-5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Income from Continuing Operations
-$489.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
1%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Income from Continuing Operations
$4.3B
CAGR 3-Years
-11%
CAGR 5-Years
17%
CAGR 10-Years
27%

See Also

What is Nurix Therapeutics Inc's Income from Continuing Operations?
Income from Continuing Operations
-143.9m USD

Based on the financial report for Nov 30, 2023, Nurix Therapeutics Inc's Income from Continuing Operations amounts to -143.9m USD.

What is Nurix Therapeutics Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-72%

Over the last year, the Income from Continuing Operations growth was 20%. The average annual Income from Continuing Operations growth rates for Nurix Therapeutics Inc have been -49% over the past three years , -72% over the past five years .

Back to Top